Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
      • Hemcast
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Hope in a Vial – The Journey Behind Vaccines

Hope in a Vial – The Journey Behind Vaccines
OUR PURPOSE/ Hope in a Vial – The Journey Behind Vaccines
August 23, 2017

A while back, I was traveling abroad on business and as is often the case in my line of work, found myself chatting with a group of mothers. Just like the moms I know back home in the U.S., they worry about their kids. But there was a major difference. These moms lived in a small village in Rwanda where access to health care is often difficult to come by. Even if they hadn’t personally lost a child – even an infant - to disease, they knew someone who had. The heartbreaking truth is that moms there often wait to name their babies until after they’ve gotten vaccinated.

That made two things devastatingly clear to me. First, every day, these families are fighting off diseases that many people in the U.S. have never heard of or forgotten are deadly. And second, while access to vaccines is common in many parts of the world, it is by no means guaranteed for these mothers or their children. 

In the world we live in today, no one should lose their life to a vaccine-preventable illness. I believe that it is our collective responsibility, and it’s something I’ve made my personal mission as the head of Pfizer’s vaccine division.

For Pfizer, solving this global public health challenge will come through innovation.

Picture a small vaccine vial, something you might remember seeing at the doctor’s office. What’s harder to envision are the hours in the lab, the hundreds of quality tests it goes through, and the thousands of people who pour their hearts into creating that single dose.

So, let’s break it down.

Every dose of one of our Pfizer vaccines requires about 400 raw materials. Here, about 1,700 employees will be involved in taking the next 580 steps to turn those ingredients into a vaccine. Then, researchers and scientists will perform 678 quality tests to make sure it will be effective once it reaches your child.

Watch this video to learn more about what goes into making a vaccine.

 

For each complete batch, from start to finish, the process takes two and a half years. That’s all for a single dose of one vaccine. That tiny vaccine vial is an incredible testament to scientific innovation – and to the passion and perseverance of the many people behind it.

But even after that long, complex process, our job isn’t done – far from it. Vaccines are only as effective as our ability to get them to the people in need. That includes those living in some of the most remote places in the world.

It is also tricky to transport vaccines. They have to be refrigerated and kept at precise temperatures ― no easy feat when reaching people who live in deserts with hundred-degree temperatures or places without paved roads or on the side of a mountain. Today, 19 million kids around the world don’t have the vaccines they need in part because they are difficult to reach.1 Just like the women I talked with in Rwanda, moms around the globe are willing to travel dozens of miles to get their children vaccinated. We owe it to them to make sure the vaccines are there when they arrive. Think of all the life milestones you’ll reach in the next 2.5 years – and know that in that same time we are spending every day making a new batch of a vaccine to help babies, parents and grandparents avoid infections to help them live their healthiest life possible and reach their dreams. So we’re working on solutions to get vaccines to people faster and more efficiently. For example, we’ve innovated ways to fit more doses into a single vaccine vial so it takes up less storage space and makes for easier transport to remote regions in many developing countries.

When I think about the journey of a vaccine – from the inventive mind of a scientist, to the skillful hands of a manufacturing expert carefully creating each dose – traveling across thousands of miles of roads and rivers to some of the world’s hardest to reach places, I think again about those mothers in Rwanda, waiting and counting on us to deliver on the promise of health and hope. This journey will culminate only when every child, teen, and adult can live to their potential with the help of disease-preventing vaccines.

Better public health is our shared challenge. Innovation is a critical part of the solution, and it’s our hope for a healthier world.

At Pfizer Vaccines, we help protect as many people as possible from life-threatening illness with quality vaccines that make an impact across all stages of life. Our employees combine unrelenting passion, global impact, and an enduring quest for progress to unlock the promise and value that vaccines hold for our world.

Learn more at www.pfizer.com/science/vaccines.

Susan Silbermann is the Head of Global Vaccines for Pfizer Inc.

By Susan Silbermann - This article originally published on Huffington Post.

1The Gates Foundation 2017 Annual Letter. (Published Februrary 14, 2017)  https://www.gatesnotes.com/2017-Annual-Letter
Related Hot Topics
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
Sandy Focuses on Diversity in Our Clinical Trials
Sandy Focuses on Diversity in Our Clinical Trials
An Early Passion for Science and Public Health Inspires Adriana’s Work
An Early Passion for Science and Public Health Inspires Adriana’s Work
“The Ice Man” - The Pfizer Colleague & Dad Who Keeps Our Medicines and Vaccines on Ice
“The Ice Man” - The Pfizer Colleague & Dad Who Keeps Our Medicines and…
Latino Colleagues at Pfizer Are Developing Potential Solutions for People Affected by COVID-19
Latino Colleagues at Pfizer Are Developing Potential Solutions for People…
Other Diseases
Deserve the Same Acceleration as
COVID-19: A BioCentury Audio Interview with Rod MacKenzie
Other Diseases Deserve the Same Acceleration as COVID-19
Moving at the Speed of Science
Moving at the Speed of Science
7 Myths About the Flu Vaccine
7 Myths About the Flu Vaccine
Tags
Corporate Responsibility
Vaccines
Vaccines & Prevention
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.